Tuberculosis (TB) is the most serious and most common opportunistic infection, and the most common cause of death in human immunodeficiency virus (HIV) patients. Globally, a significant challenge to achieving universal access to HIV prevention, treatment, care and support is the optimization of imaging. In this regard, nuclear medicine with both positron emission tomography (PET) and single-photon emission computed tomography (SPECT) is an integral part of infection imaging. HIV primarily infects and kills helper T cells (CD4+ T cells), macrophages and dendritic cells. In HIV/acquired immunodeficiency syndrome (AIDS) and TB infection, early identification and diagnosis of active TB is the key to effective control of the disease. Patients with HIV-1 are at risk for lymphoma, making the differential diagnosis between benign and malignant lymphadenopathy imperative. In developing countries, multidrug resistant (MDR) and extensively drug resistant (XDR) TB are of serious consequence and thus monitoring of therapy is essential.

Nuclear Medicine Imaging of Tuberculosis and Human Immunodefi ciency Virus / Sathekge, M.; Van de Wiele, C.; Signore, A.. - (2013), pp. 255-272. [10.1002/9781118484388.ch15].

Nuclear Medicine Imaging of Tuberculosis and Human Immunodefi ciency Virus

Signore A.
2013

Abstract

Tuberculosis (TB) is the most serious and most common opportunistic infection, and the most common cause of death in human immunodeficiency virus (HIV) patients. Globally, a significant challenge to achieving universal access to HIV prevention, treatment, care and support is the optimization of imaging. In this regard, nuclear medicine with both positron emission tomography (PET) and single-photon emission computed tomography (SPECT) is an integral part of infection imaging. HIV primarily infects and kills helper T cells (CD4+ T cells), macrophages and dendritic cells. In HIV/acquired immunodeficiency syndrome (AIDS) and TB infection, early identification and diagnosis of active TB is the key to effective control of the disease. Patients with HIV-1 are at risk for lymphoma, making the differential diagnosis between benign and malignant lymphadenopathy imperative. In developing countries, multidrug resistant (MDR) and extensively drug resistant (XDR) TB are of serious consequence and thus monitoring of therapy is essential.
2013
Diagnostic Imaging of Infections and Inflammatory Diseases: A Multidisciplinary Approach
9781118484388
9781118484418
human immunodeficiency virus (hiv); nuclear medicine imaging; tuberculosis (tb)
02 Pubblicazione su volume::02a Capitolo o Articolo
Nuclear Medicine Imaging of Tuberculosis and Human Immunodefi ciency Virus / Sathekge, M.; Van de Wiele, C.; Signore, A.. - (2013), pp. 255-272. [10.1002/9781118484388.ch15].
File allegati a questo prodotto
File Dimensione Formato  
Sathekge_Nuclear_2013.pdf

solo gestori archivio

Note: Chapter 15
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 736.64 kB
Formato Adobe PDF
736.64 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1414473
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact